New hope for knee pain sufferers? drug HRS-2129 enters human trials
NCT ID NCT07351968
First seen Jan 20, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This study tests a new drug called HRS-2129 in 200 people with moderate to severe knee osteoarthritis pain. The goal is to see if different doses can reduce pain and improve knee function, while also checking safety. Participants must stop other pain treatments during the study, except for a basic rescue medicine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE AND SEVERE PAIN IN KNEE OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Drum Tower Hospital affiliated to Nanjing University School of Medicine
RECRUITINGNanjing, Jiangsu, 210005, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.